These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2181314)

  • 21. Pathogenesis of lymphatic disease in bancroftian filariasis: a clinical perspective.
    Dreyer G; Norões J; Figueredo-Silva J; Piessens WF
    Parasitol Today; 2000 Dec; 16(12):544-8. PubMed ID: 11121854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of ivermectin for control of microfilaremia recurring after treatment with diethylcarbamazine. I. Clinical and parasitologic observations.
    Zheng HJ; Piessens WF; Tao ZH; Cheng WF; Wang SH; Cheng SH; Ye YM; Luo LF; Chen XR; Gan GB
    Am J Trop Med Hyg; 1991 Aug; 45(2):168-74. PubMed ID: 1877711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imported bancroftian filariasis: diethylcarbamazine response and benzimidazole susceptibility of Wuchereria bancrofti in dynamic cross-border migrant population targeted by the National Program to Eliminate Lymphatic Filariasis in South Thailand.
    Bhumiratana A; Pechgit P; Koyadun S; Siriaut C; Yongyuth P
    Acta Trop; 2010 Feb; 113(2):121-8. PubMed ID: 19835831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A placebo-controlled double-blind trial for the treatment of bancroftian filariasis with ivermectin or diethylcarbamazine.
    Sabry M; Gamal H; el-Masry N; Kilpatrick ME
    Trans R Soc Trop Med Hyg; 1991; 85(5):640-3. PubMed ID: 1780996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elimination of transmission of lymphatic filariasis in Egypt.
    Molyneux DH
    Lancet; 2006 Mar; 367(9515):966-8. PubMed ID: 16564345
    [No Abstract]   [Full Text] [Related]  

  • 26. A new tool to assess the adulticidal efficacy in vivo of antifilarial drugs for bancroftian filariasis.
    Dreyer G; Amaral F; Norões J; Medeiros Z; Addiss D
    Trans R Soc Trop Med Hyg; 1995; 89(2):225-6. PubMed ID: 7778157
    [No Abstract]   [Full Text] [Related]  

  • 27. Impact of single dose of diethylcarbamazine and other antifilarial drug combinations on bancroftian filarial infection variables: assessment after 2 years.
    Sunish IP; Rajendran R; Mani TR; Munirathinam A; Reuben R; Dash AP
    Parasitol Int; 2006 Sep; 55(3):233-6. PubMed ID: 16807079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of high dose ivermectin and diethylcarbamazine for activity against bancroftian filariasis in Haiti.
    Richards FO; Eberhard ML; Bryan RT; McNeeley DF; Lammie PJ; McNeeley MB; Bernard Y; Hightower AW; Spencer HC
    Am J Trop Med Hyg; 1991 Jan; 44(1):3-10. PubMed ID: 1996738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards eliminating lymphatic filariasis in Papua New Guinea: impact of annual single-dose mass treatment on transmission of Wuchereria bancrofti in East Sepik Province.
    Bockarie MJ; Ibam E; Alexander ND; Hyun P; Dimber Z; Bockarie F; Alpers MP; Kazura JW
    P N G Med J; 2000; 43(3-4):172-82. PubMed ID: 11939298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distended thoracic duct and diffuse lymphangiectasia caused by bancroftian filariasis.
    Ahn PJ; Bertagnolli R; Fraser SL; Freeman JH
    AJR Am J Roentgenol; 2005 Oct; 185(4):1011-4. PubMed ID: 16177425
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical manifestations of lymphatic bancroftian filariasis].
    Dreyer G; Coutinho A; Albuquerque R
    AMB Rev Assoc Med Bras; 1989; 35(5):189-96. PubMed ID: 2486416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety trial of single-dose treatments with a combination of ivermectin and diethylcarbamazine in bancroftian filariasis.
    Moulia-Pelat JP; Nguyen LN; Glaziou P; Chanteau S; Gay VM; Martin PM; Cartel JL
    Trop Med Parasitol; 1993 Jun; 44(2):79-82. PubMed ID: 8367670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of two different DEC regimens in the treatment of human filarial infection.
    Prasad GB; Ramaprasad P; Rao VS; Bharati MS; Harinath BC
    Indian J Med Res; 1990 Mar; 91():133-7. PubMed ID: 2188905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The treatment of microfilaremia due to Wuchereria bancrofti var. pacifica: ivermectin versus diethylcarbamazine].
    Cartel JL; Spiegel A; Nguyen L; Plichart R; Martin PM; Roux JF
    Ann Soc Belg Med Trop; 1991 Sep; 71(3):229-36. PubMed ID: 1958108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of ivermectin for control of microfilaremia recurring after treatment with diethylcarbamazine. II. Immunologic changes following treatment.
    Zheng HJ; Tao ZH; Cheng WF; Wang SH; Cheng SH; Ye YM; Luo LF; Chen XR; Gan GB; Piessens WF
    Am J Trop Med Hyg; 1991 Aug; 45(2):175-81. PubMed ID: 1877712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistence of parasite antigenemia following diethylcarbamazine therapy of bancroftian filariasis.
    Weil GJ; Sethumadhavan KV; Santhanam S; Jain DC; Ghosh TK
    Am J Trop Med Hyg; 1988 May; 38(3):589-95. PubMed ID: 3079315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diethylcarbamazine treatment of bancroftian and malayan filariasis with emphasis on side effects.
    Fan PC
    Ann Trop Med Parasitol; 1992 Aug; 86(4):399-405. PubMed ID: 1463361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of 10 years of diethylcarbamazine and ivermectin mass administration on infection and transmission of lymphatic filariasis.
    Ramaiah KD; Das PK; Vanamail P; Pani SP
    Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):555-63. PubMed ID: 17374389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study.
    Stolk WA; Swaminathan S; van Oortmarssen GJ; Das PK; Habbema JD
    J Infect Dis; 2003 Nov; 188(9):1371-81. PubMed ID: 14593597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of exposure to Bancroftian filariasis in a traveller to Thailand.
    Shaw MT; Leggat PA
    Travel Med Infect Dis; 2006 Sep; 4(5):290-3. PubMed ID: 16905461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.